A group of experts that advises the US Centers for Disease Control and Prevention on its vaccine recommendations has suspended an anticipated push to stop recommending mRNA-based Covid-19 vaccines ...

Several states have issued their own guidance about COVID-19 vaccines since the FDA released its 2025-2026 formula approvals on Aug. 27, significantly restricting who can access the vaccines for the ...

An early Moderna COVID‑19 trial has resurfaced six years on, amid ongoing debate over vaccine risks, guidance and public trust.

Updated mRNA-1273 vaccine was effective against severe COVID-19 outcomes in older and high-risk adults during the 2024-2025 season.

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

Vials of the Pfizer-BioNTech COVID-19 vaccine are shown in 2023. It was formulated using mRNA technology. Lee S. Weissman USA TODAY NETWORK COLUMBIA, S.C. Before receiving another dose of a COVID-19 ...

GREELEY, Colo. - The push to get more Americans vaccinated went up a notch after JBS USA and Pilgrim's announced they will give away free beef, pork and chicken for a year to 50 families who get the ...

A dismantled health infrastructure leaves the U.S. incredibly vulnerable, warns infectious-disease expert Michael Osterholm.

You can’t blame this one on the stork. After a brief baby bump early in the COVID-19 pandemic, birth rates in the US and other wealthy countries dropped as the public health emergency eased. That ...

Six years ago, on March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. Here's what else ...

Moderna (NASDAQ:MRNA) has agreed to pay US$950 million to resolve a long-running patent dispute tied to the technology used ...